Incidence and correlates of HIV exclusion criteria in cancer clinical trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and correlates of HIV exclusion criteria in cancer clinical trials

Published:2019-12-02 Issue:8 Volume:146 Page:2362-2364
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Ludmir Ethan B.¹^ORCID,Espinoza Andres F.²,Jethanandani Amit¹³,Lin Timothy A.⁴,Mainwaring Walker²,Miller Austin B.⁵,Das Prajnan¹

Affiliation:

1. The University of Texas MD Anderson Cancer Center Houston TX

2. Baylor College of Medicine Houston TX

3. The University of Tennessee Health Science Center College of Medicine Memphis TN

4. The Johns Hopkins University School of Medicine Baltimore MD

5. The University of Texas Health Science Center McGovern Medical School Houston TX

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32800

Reference10 articles.

1. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology–Friends of Cancer Research HIV Working Group

2. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation

3. Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement

4. Cancer clinical trials in persons with HIV infection

5. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab in an HIV-infected patient with glioblastoma;Immunotherapy;2024-06-18

2. NLP Applications—Other Biomedical Texts;Cognitive Informatics in Biomedicine and Healthcare;2024

3. Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials;Seminars in Radiation Oncology;2023-10

4. Selection and Prejudice: Addressing Clinical Trial Disparities With a Review of Current Shortcomings and Future Directions;Seminars in Radiation Oncology;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3